EchoSolv AS vs Viz HCM

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Echo IQ
VS
by Viz.ai

AI Verdict

EchoSolv AS is designed to identify patients at risk for severe aortic stenosis by analyzing echocardiogram measurements, offering clinical decision support and study prioritization. In contrast, Viz HCM uses real-time ECG analysis to detect suspected hypertrophic cardiomyopathy and focuses on intelligent care coordination with mobile alerts. While both are FDA-cleared AI tools for cardiology, their distinct target conditions and input data sources make them suitable for different diagnostic and workflow applications.

Choose EchoSolv AS if…

Choose EchoSolv AS if your primary need is to accurately and efficiently identify patients at high risk for severe aortic stenosis using existing echocardiogram measurements. This tool is ideal for cardiology departments seeking to prioritize studies for closer review and streamline their diagnostic workflow without requiring extensive EMR integration.

View EchoSolv AS →

Choose Viz HCM if…

Choose Viz HCM if your priority is real-time detection of suspected Hypertrophic Cardiomyopathy directly from ECG analysis and immediate, coordinated care team activation. This solution is best suited for health systems aiming to significantly reduce HCM diagnosis time and automate patient direction to appropriate specialists through seamless integration with EHR and PACS.

View Viz HCM →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature EchoSolv AS Viz HCM
Deployment Cloud-based Unknown
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz HCM

While both tools integrate into existing workflows, Viz HCM offers a more comprehensive and proactive user experience. It provides real-time detection, mobile-based alerts, and automated care coordination, which streamlines workflows for multidisciplinary teams. EchoSolv AS focuses on ultra-fast analysis and PACS integration without requiring EMR integration, which is simpler but less integrated into the broader care pathway.

Clinical Value

Viz HCM

Both tools are FDA-cleared and offer significant clinical value for their respective conditions. Viz HCM explicitly highlights 'extensive real-world evidence and publications' and focuses on 'significantly reducing diagnosis time' and 'time to treatment' for HCM. EchoSolv AS also demonstrates high accuracy and efficiency in identifying severe AS, with studies showing it can outperform traditional interpretation and reduce delays in diagnosis. However, Viz HCM's emphasis on reducing time to *treatment* and its broad publication record give it a slight edge in demonstrating tangible impact on patient outcomes.

Pricing & Value

Viz HCM

Viz HCM provides transparent information about its subscription-based pricing model and, critically, mentions CMS reimbursement available for specific CPT codes (0764T and 0765T). This clear path to reimbursement significantly enhances its financial value proposition for healthcare systems. EchoSolv AS, while also subscription-based and having a mapped pathway toward a dedicated Category III CPT code expected in mid-2025, does not provide specific pricing details or current reimbursement codes in the provided information, making a direct comparison of value difficult.

Enterprise Readiness

Viz HCM

Both tools are cloud-based, FDA-cleared, HIPAA compliant, and have BAAs, indicating strong foundational enterprise readiness. However, Viz HCM explicitly states 'integrated into hospital IT systems (EHR, PACS)' and 'seamless integration with existing clinical workflows, EHR, and PACS systems,' suggesting a deeper and broader integration capability within complex hospital IT ecosystems. While EchoSolv AS emphasizes 'no EMR integration required,' Viz HCM's comprehensive EHR integration points to a more holistic enterprise solution.

Innovation

Viz HCM

While EchoSolv AS demonstrates innovation with its 'measurement-based AI' that analyzes numerical data and 'ultra-fast risk detection' (under 3 seconds), Viz HCM's innovation extends beyond just detection. Viz HCM integrates AI into 'real-time disease detection,' 'mobile-based alerts,' and 'automated direction of patients to appropriate care specialists,' representing a broader innovation in care coordination and workflow automation driven by AI. This proactive approach to transforming the entire care pathway gives Viz HCM an edge in innovation.

Support & Docs

Viz HCM

Viz HCM explicitly details its customer support, including a dedicated customer success team, clinical and workflow specialists, and 24/7 urgent support via phone and in-app contact. EchoSolv AS mentions 'Feedback & Support' on its website but does not provide specific details on support tiers, documentation, or response times. Therefore, Viz HCM demonstrates a more robust and transparent support structure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature EchoSolv AS Viz HCM
Target Condition Severe Aortic Stenosis (sAS) Hypertrophic Cardiomyopathy (HCM)
Analysis Method AI-powered clinical decision support for severe aortic stenosis probability, measurement-based AI (analyzes numerical measurements, not images) AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection, real-time disease detection from electrocardiograms
Data Input Numerical measurements (AI does not use LVOT measurements) Real-time ECG analysis
System Integration Designed to fit existing workflows (no EMR integration required, integrates with PACS) Seamless integration with existing clinical workflows, EHR, and PACS systems
Alerts/Notifications Second reader support to help prioritize studies for closer review Mobile-based alerts and notifications to multidisciplinary care teams, automated direction of patients to appropriate care specialists
Primary Specialties Cardiology, Cardiothoracic Surgery Cardiology, Emergency Medicine, Hospital Medicine

Videos

Demos, reviews, and walkthroughs featuring EchoSolv AS and Viz HCM.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

EchoSolv AS is an AI-powered clinical decision support platform that analyzes echocardiograms to identify patients at risk for severe aortic stenosis. Viz HCM is an AI tool that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM).
EchoSolv AS analyzes numerical measurements from echocardiograms to assess the probability of severe aortic stenosis. Viz HCM analyzes real-time ECGs to detect suspected Hypertrophic Cardiomyopathy.
EchoSolv AS is designed to fit existing workflows, integrating with PACS and not requiring EMR integration. Viz HCM is a cloud-based platform integrated into hospital IT systems, including EHR and PACS, and streamlines cardiac care coordination and clinical workflows.
EchoSolv AS provides AI-powered clinical decision support for severe AS probability, offering consistent assessment and second reader support to help prioritize studies. Viz HCM offers real-time disease detection from ECGs, mobile-based alerts to multidisciplinary care teams, and automated direction of patients to appropriate care specialists, aiming to reduce time to diagnosis and treatment for HCM.
Viz HCM has CMS reimbursement available for CPT codes 0764T and 0765T, with a national payment rate of $128.90, effective January 1, 2025. EchoSolv AS is working to obtain reimbursement codes for its use under insurance.
EchoSolv AS offers ultra-fast risk detection in under 3 seconds. Viz HCM provides real-time disease detection from electrocardiograms.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.